Microphyt

Based in France, Microphyt specializes in developing and marketing microalgae-based natural ingredients aimed at the nutrition and beauty sectors, leveraging biotechnology to create innovative health solutions. Microphyt, founded in 2007 in France, focuses on creating high-value microalgae-based products. The company has successfully raised EUR 15. 04 mn in its Series B funding round in December 2022, led by L'Oréal BOLD Ventures and supported by prominent investors including Bpifrance and Sofinnova Partners.

The CEO of Microphyt is Vincent Usache. Microphyt specializes in developing and marketing microalgae-based natural ingredients primarily for the nutrition and beauty sectors. The company's core product offerings include bioactive compounds that leverage unique microalgae diversity to create innovative solutions for health and well-being. Notable products include Luteana™, which enhances scalp health, and DunaPure™, targeting skin imperfections.

Microphyt serves various industries including nutraceuticals and cosmetics, primarily in Europe, North America, and Asia, with an emphasis on eco-efficient solutions that align with contemporary consumer demands. In the most recent year, 2021, Microphyt generated revenue of EUR 846,111. 4, though it recorded an EBITDA loss of EUR 2,040,867. 6.

With the EUR 15. 04 mn raised in the Series B funding round in December 2022, Microphyt plans to accelerate the development of eco-designed ingredients and enhance its production capabilities. This funding will support the introduction of new products and expand their presence in existing markets, particularly targeting growth in North America and Asia by 2024.